The study therefore identifies cTnT as the preferred biomarker for diagnosis, risk stratification, and follow-up in ICI-related myocarditis, suggesting that current diagnostic recommendations should be reconsidered [37]. The gene discussed is TNNT2; the disease is myocarditis.